The Evolving Treatment Landscape in Paroxysmal Nocturnal Hemoglobinuria
OncLive,
Muthu Veeraputhiran, MD Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired stem cell disorder that leads to hemolysis.
Muthu Veeraputhiran, MD Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired stem cell disorder that leads to hemolysis.
ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults with Paroxysmal Nocturnal…
BOSTON--( BUSINESS WIRE )-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the European Commission has…
ULTOMIRIS ® (ravulizumab) Receives Marketing Authorization from European Commission for Adults with Paroxysmal Nocturnal…